Methods and systems for multi-stage drying of plasma

Patent metadata

Field	Value
Publication number	US-9561184-B2
Application number	US-201514670127-A
Country	US
Kind code	B2
Filing date	Mar 26, 2015
Priority date	Sep 19, 2014
Publication date	Feb 7, 2017
Grant date	Feb 7, 2017

Abstract

Disclosed are methods of spray drying blood plasma using a two-step drying process.

First claim

We claim:

1. A method for spray drying blood plasma, the method comprising:
providing a spray drier device having a collection bag;
providing blood plasma;
spray drying the blood plasma using the spray drier device to produce a dried plasma product recovered in the collection bag, said dried plasma product having a moisture content at a first moisture level, wherein the first moisture level is associated with a substantially non-clumping dried plasma;
removing the collection bag containing the dried plasma product from the spray drier device and sealing the dried plasma product in a vapor permeable container;
incubating the sealed vapor permeable container containing dried plasma product in vapor communication with a desiccant material stored in a container, located outside the sealed vapor permeable container having sufficient capacity to lower the moisture content of the dried plasma product from the first moisture level to produce a dried plasma product at a second moisture level.

2. The method of claim 1 , wherein the vapor permeable container is the collection bag.

3. The method of claim 1 , wherein a plasma factor activity in the dried plasma product is determined to retain a greater activity through storage at the second moisture level relative to storage at the first moisture level.

4. The method of claim 1 , wherein the first moisture level is from about 3.5% w/w to about 9.5% w/w.

5. The method of claim 1 , wherein the second moisture level is from about 1.5% w/w to about 6.0% w/w.

6. The method of claim 1 , wherein a mass of desiccant material is provided as a function of a mass of the dried plasma product, the first moisture level, and the second moisture level.

7. The method of claim 1 , wherein a mass of desiccant material is provided as a function of storage temperature.

8. The method of claim 1 , wherein incubating the dried plasma product further comprises storing both the collection bag and the desiccant material within a sealed, vapor impermeable storage pouch.

9. The method of claim 1 , further comprising storing an oxygen scavenger material outside of the collection bag, wherein the dried plasma maintains vapor communication with the oxygen scavenger material through the collection bag.

10. The method of claim 1 , wherein said collection bag is sealed prior to being removed from the spray drier device.

11. The method of claim 10 , wherein a mass of desiccant material is provided as a function of a mass of the dried plasma product, the first moisture level, and the second moisture level.

12. The method of claim 1 , wherein the sealed vapor permeable container containing dried plasma product is in vapor communication with a composition consisting of desiccant material located outside the sealed vapor permeable container.

13. A method for storing dried plasma product, the method comprising:
providing a spray dryer, a vapor-permeable collection bag, a vapor impermeable storage pouch, desiccant and blood plasma
drying the blood plasma in the spray dryer to produce a dried plasma product containing preserved blood plasma clotting factors, the dried plasma product having a moisture content at a first moisture level, wherein the first moisture level is associated with a substantially non-clumping dried plasma product, and
collecting the dried plasma product in the vapor permeable collection bag;
placing the collection bag containing the dried plasma product in the vapor non-permeable storage pouch containing the desiccant wherein the desiccant is located in a container in the storage pouch outside the collection bag; wherein the desiccant is selected at an amount sufficient to absorb moisture from the dried plasma through the collection bag and to lower the moisture content of the dried plasma product to a desired second moisture level and wherein the desired second moisture level is selected for a combination of stability and preservation of the clotting factors.

14. The method of claim 13 , wherein the collection bag comprises:
an internal filter bag for containing the dried plasma product; and
an external bag for containing the filter bag, wherein both the filter bag and the external bag are vapor permeable.

15. The method of claim 14 , wherein the external bag comprises polyvinyl chloride (PVC).

16. The method of claim 14 , wherein the filter bag comprises 0.2 micron filter material.

17. The method of claim 13 , wherein the first moisture level is from about 3.5% w/w to about 9.5% w/w.

18. The method of claim 13 , wherein the second moisture level is from about 1.5% w/w to about 6.0% w/w.

19. The method of claim 13 , wherein a mass of desiccant is provided as a function of storage temperature.

20. The method of claim 13 , wherein the sealed vapor permeable container containing dried plasma product is in vapor communication with a composition consisting of desiccant material located outside the sealed vapor permeable container.

Assignees

• Velico Medical Inc

Inventors

• Khan Abdul Wahid
• Wilt Michael
• Lucien Rud Karly
• Sohn Jihae
• Liu Qiyong Peter

Classifications

• A61K9/1688 Primary

  resulting in pure drug agglomerate optionally containing up to 5% of excipient · CPC title

• F26B5/04

  by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum {(F26B11/049 and F26B17/128 take precedence)} · CPC title

• A61K9/1682 Primary

  Processes · CPC title

• B65D81/266

  for absorbing gases, e.g. oxygen absorbers or desiccants (B65D51/244, B65D51/30 take precedence) · CPC title

• F26B3/06

  the gas or vapour flowing through the materials or objects to be dried (F26B3/14 takes precedence) · CPC title